Literature DB >> 11430032

Total synthesis of (-)-stellettamide B and determination of its absolute stereochemistry.

N Yamazaki1, W Dokoshi, C Kibayashi.   

Abstract

[figure: see text] The first total synthesis of (-)-stellettamide B has been achieved by a sequence based on amide coupling of the chiral 1-(aminomethyl)-indolizidine fragment, prepared by TiCl4-mediated asymmetric allylation of the tricyclic N-acyl-N,O-acetal, with the chiral trienoic acid fragment. This synthesis led to revision of the published relative stereochemistry of the natural product and established its absolute stereochemistry to be 1S,4S,8aR,6"R.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430032     DOI: 10.1021/ol0003228

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Nature-inspired stereospecific total synthesis of P-(+)-dispegatrine and four other monomeric sarpagine indole alkaloids.

Authors:  Chitra R Edwankar; Rahul V Edwankar; Jeffrey R Deschamps; James M Cook
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-16       Impact factor: 15.336

2.  Stereospecific approach to the synthesis of ring-A oxygenated sarpagine indole alkaloids. Total synthesis of the dimeric indole alkaloid P-(+)-dispegatrine and six other monomeric indole alkaloids.

Authors:  Chitra R Edwankar; Rahul V Edwankar; Ojas A Namjoshi; Xuebin Liao; James M Cook
Journal:  J Org Chem       Date:  2013-06-18       Impact factor: 4.354

Review 3.  Enzymatic Kinetic Resolution of 2-Piperidineethanol for the Enantioselective Targeted and Diversity Oriented Synthesis.

Authors:  Dario Perdicchia; Michael S Christodoulou; Gaia Fumagalli; Francesco Calogero; Cristina Marucci; Daniele Passarella
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

4.  Total Synthesis of (-)-Anaferine: A Further Ramification in a Diversity-Oriented Approach.

Authors:  Elisa Bonandi; Giada Tedesco; Dario Perdicchia; Daniele Passarella
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.